BackOrion Biotech Opportunities Overview

Orion Biotech Opportunities Total Liabilities

Latest total liabilities for ORIA: $8.3M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$8.33M
44.88% YoYΔ $-6.79M vs prior year quarter

Peer average

Loading

Orion Biotech Opportunities Total Liabilities History

Loading

Orion Biotech Opportunities vs. peers: Total Liabilities Comparison

Loading

Orion Biotech Opportunities Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orion Biotech Opportunities (ORIA) FAQ

As of the most recent data (December 2022), ORIA shows a total liabilities of $8.3M. That compares with $15M in the prior-year period — down 44.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORIA's total liabilities is now $8.3M (was $15M) — a 44.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orion Biotech Opportunities is outperforming or lagging.

Tracking ORIA's total liabilities over time shows whether Orion Biotech Opportunities is scaling, shrinking, or reshaping that part of the business. The current reading is $8.3M That compares with $15M in the prior-year period — down 44.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Orion Biotech Opportunities's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $8.3M) with ownership activity and broader fundamentals.